Drug Policy Network South East Europe

Drug Policy Advocacy & Harm Reduction Network Servicesdpnsee.org

Drug Policy Network South East Europe (DPNSEE) is a non-profit civil society network founded in 2015 that coordinates 27 member organisations across 11 South East European countries to advance humane drug policies, harm reduction, and HIV response through advocacy, training, and knowledge sharing.

Company typePrivate
Founded-
HeadquartersBelgrade (Zemun), Serbia
Headcount1–10
GTM typeB2B
OfferingServices

What Drug Policy Network South East Europe does

Drug Policy Network South East Europe (DPNSEE) is a non-profit civil society network founded in 2015 and headquartered in Zemun (Belgrade), Serbia. It coordinates 27 member organisations (24 ordinary, 2 associate, plus honorary) across 11 South East European countries, including Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Greece, Kosovo, Montenegro, North Macedonia, Romania, Serbia, Slovenia, and Turkey. Its mission is to advance more humane and effective drug policies in the region through advocacy, knowledge sharing, and capacity building among member organisations that provide preventive, therapeutic, harm reduction, and rehabilitation services to people who use drugs and other key affected populations. DPNSEE operates as a regional convening body with direct engagement at UN agencies (CND, UNODC, UNAIDS, WHO, UNDP, EMCDDA, ECDC) and is a member of the Vienna NGO Committee on Drugs (VNGOC), the International Drug Policy Consortium (IDPC), and Correlation European Network on Social Inclusion and Health.

DPNSEE's product portfolio is digital and informational rather than commercial. The core offerings include the NextGen Harm Reduction Online Learning Platform (a six-module digital learning platform for harm reduction professionals, launched May 2026 under the Erasmus+ programme), a Resource Centre for knowledge sharing, a Glossary of drug policy terms, a publications and documents repository, Web Outreach Services (anonymous peer consultations via Zoom), and a regular news and newsletter service. The technology stack is built on standard web and communication tools: WordPress-based website, MailChimp for email distribution, Google Analytics and AddThis for traffic analysis, Zoom for webinars and consultations, YouTube for video content, and Zoho Survey for registration forms. The platform is operated by a small team of approximately 5 employees.

DPNSEE's business model is institutional grant funding, not commercial revenue. Founding was supported by the European Commission (DG for Neighbourhood and Enlargement Negotiations) and Open Society Foundations. Current institutional support comes from Open Society Foundations, with additional project-specific funding from Erasmus+, RYCO, and other EU mechanisms. The network does not charge for its services and membership is free for qualifying civil society organisations. Primary customers are member organisations (civil society service providers) and the ultimate beneficiaries are people who use drugs and key affected populations receiving harm reduction, HIV prevention, and treatment services.

Drug Policy Network South East Europe firmographics

Firmographics

Name: Drug Policy Network South East Europe
Legal name: Drug Policy Network South East Europe
Website: https://dpnsee.org
Company type: Private
Operating status: Operating
Headcount range: 1–10 employees
Short description: Drug Policy Network South East Europe (DPNSEE) is a non-profit civil society network founded in 2015 that coordinates 27 member organisations across 11 South East European countries to advance humane drug policies, harm reduction, and HIV response through advocacy, training, and knowledge sharing.
Ownership category
akta.pro rank

Drug Policy Network South East Europe industry classification

Industry

Product category: Drug Policy Advocacy & Harm Reduction Network Services
NAICS: Voluntary Health Organizations (813212), Social Advocacy Organizations (8133)
SIC: Services-Membership Organizations (8600), Services-Social Services (8300)
akta.pro industry: PRIMARYBPAGACAE
Substance Use Disorder Prevention & Recovery Services
Business & Public Services/Nonprofit, NGO & Social Services/Health & Medical Nonprofits
SECONDARYBPAGAEAO
Substance Use Recovery & Harm Reduction Support Services
Business & Public Services/Nonprofit, NGO & Social Services/Social Services & Community Support (Food, Housing, Family)

Keywords

Drug policy advocacy
Harm reduction services
Civil society network
HIV prevention programs
Capacity building training

Where Drug Policy Network South East Europe is headquartered

Location

Headquarters

HQ city: Belgrade (Zemun)
HQ country: Serbia
HQ region: Europe

Offices1 record

Markets served

Drug Policy Network South East Europe business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

Institutional Funding: DPNSEE operates as a non-profit organization funded primarily through institutional grants. Founding supported by European Commission DG for Neighbourhood and Enlargement Negotiations and Open Society Foundations. Current institutional support from Open Society Foundations.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Drug Policy Network South East Europe product offering

Product offering

Core offering

Drug Policy Network South East Europe (DPNSEE) is a civil society network that coordinates 27 member organisations across 11 South East European countries to advocate for humane, evidence-based drug policies. It delivers regional advocacy at UN bodies (CND, UNODC, UNAIDS, WHO), provides training through projects such as the NextGen Harm Reduction Online Learning Platform, and facilitates knowledge sharing via a Resource Centre, publications, webinars, and Web Outreach consultation services on harm reduction and psychoactive substances.

Product overview

Drug Policy Network South East Europe operates primarily as an informational and advocacy platform offering multiple interconnected digital services. The core portfolio includes the NextGen Harm Reduction Online Learning Platform (a digital education platform with six thematic modules on harm reduction and new psychoactive substances, issuing certificates upon completion), a Resource Centre for sharing information and resources among member organisations, a Glossary of drug policy terms, Publications and Documents (research reports, guidance notes, and regional analyses), Web Outreach Services (anonymous peer consultations via Zoom on harm reduction topics), and News/Newsletter distribution. The organization coordinates regional cooperation, advocates for evidence-based drug policies, and facilitates knowledge exchange among civil society organisations across 11 South East European countries.

Differentiator

Problem solved

Functional benefit

Products and services

NextGen Harm Reduction Online Learning Platform A digital learning platform developed within the NextGen Harm Reduction (NEHRD) project for capacity building among professionals working in harm reduction, healthcare, social protection, outreach services, education, youth work, research, policy development, and civil society. Features six thematic modules and issues certificates upon course completion.
Web Outreach Services Online consultation services provided via Zoom offering anonymous and confidential peer consultations on harm reduction, psychoactive substance use, NPS, stimulants, and related risks. Includes referral services for HIV, HCV, STI testing and substance use disorder consultations.
Resource Centre An online repository facilitating sharing of information, resources, and experiences between member organisations and other civil society organisations. Provides useful training, practical information, and services while strengthening relationships and enhancing dialogue between CSOs and other actors.
Publications and Documents A collection of publications including research reports, guidance notes, guides, and documents covering topics such as decriminalization, harm reduction, gender sensitivity, discrimination, drug education, and regional cooperation in South East Europe.

Companies that use Drug Policy Network South East Europe

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Drug Policy Network South East Europe technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature1 record

Drug Policy Network South East Europe partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core and major.

Vienna NGO Committee on Drugs (VNGOC)coreStrategic or Co-development PartnerDPNSEE is a member of VNGOC, which serves as a vital link between NGOs and key intergovernmental and international agencies involved in drug policy, including the Commission on Narcotic Drugs (CND), International Narcotics Control Board, and UNODC.
International Drug Policy Consortium (IDPC)coreStrategic or Co-development PartnerDPNSEE is a member of IDPC, a global network promoting objective and open debate on drug policy. This provides DPNSEE with international advocacy capacity and access to global drug policy expertise.
Correlation - European Network on Social Inclusion and HealthcoreStrategic or Co-development PartnerDPNSEE is a member of Correlation, which connects harm reduction services, grassroots organizations, community-based services, research institutes and health facilities from all over Europe.
Re Generation (Serbia)coreStrategic or Co-development PartnerDPNSEE cooperation partner in the NextGen Harm Reduction project. Re Generation developed the digital learning platform for harm reduction training. DPNSEE participates in regional workshops and events coordinated by Re Generation.
GAT (Portugal)majorStrategic or Co-development PartnerPartner in the NextGen Harm Reduction (NEHRD) project implementing the Erasmus+ programme, working on emerging psychoactive drugs and harm reduction responses.
ARAS (Romania)majorStrategic or Co-development PartnerPartner in the NextGen Harm Reduction (NEHRD) project implementing the Erasmus+ programme, working on emerging psychoactive drugs and harm reduction responses.
HOPS (North Macedonia)majorStrategic or Co-development PartnerPartner in the NextGen Harm Reduction (NEHRD) project implementing the Erasmus+ programme, working on emerging psychoactive drugs and harm reduction responses.
Eurasian Harm Reduction Association (EHRA)coreStrategic or Co-development PartnerDPNSEE works with EHRA on the BOOST project, joint webinars on decriminalization, harm reduction crisis advocacy, and regional cooperation on HIV and viral hepatitis.
Correlation - European Harm Reduction NetworkcoreStrategic or Co-development PartnerDPNSEE collaborates with Correlation on harm reduction crisis advocacy in SEE, joint webinars, and civil society monitoring of harm reduction services.
UNAIDScoreStrategic or Co-development PartnerDPNSEE endorsed joint letter to UN General Assembly President regarding 2026 High-Level Meeting on HIV/AIDS. Collaboration on guidance notes regarding decriminalization and HIV response.
UNDPcoreStrategic or Co-development PartnerDPNSEE collaborates with UNDP on HIV response, social contracting mechanisms, and international guidelines on human rights and drug policy.
World Health Organisation (WHO)coreStrategic or Co-development PartnerDPNSEE works with WHO on harm reduction guidance, needle and syringe programmes, and international health standards for people who use drugs.
European Centre for Disease Prevention and Control (ECDC)majorStrategic or Co-development PartnerDPNSEE references ECDC guidance on infectious diseases among people who inject drugs and uses ECDC surveillance data for HIV/AIDS in the region.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)coreStrategic or Co-development PartnerDPNSEE collaborates with EMCDDA on drug policy webinars, EU Drugs Strategy dissemination, and joint guidance on infectious diseases among people who inject drugs.
Regional Youth Cooperation Office (RYCO)majorStrategic or Co-development PartnerDPNSEE received funding through RYCO's 4th Open Call co-financed by the European Union for the 'No Risk, No Borders for Young People' project.
United Nations Office on Drugs and Crime (UNODC)coreStrategic or Co-development PartnerDPNSEE participates in CND sessions organized by UNODC. Member organisation Re Generation receives UNODC funding for HIV and harm reduction services project for Ukraine refugees.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Drug Policy Network South East Europe competitors and assessment

Company assessment

Direct peers

International Drug Policy Consortium (IDPC): Global network of NGOs promoting objective and open debate on drug policy. DPNSEE is a member of IDPC and operates a regional chapter-like function for SEE, making it a direct peer in drug policy advocacy and network coordination.
Eurasian Harm Reduction Association (EHRA): Regional harm reduction network covering Eastern Europe and Central Asia, focused on HIV, viral hepatitis, and harm reduction advocacy. Closely comparable regional NGO network already collaborating with DPNSEE on the BOOST project and joint webinars.
Transform Drug Policy Foundation: UK charity advocating for drug policy reform and end to drug prohibition. Operates a comparable single-issue drug policy reform advocacy model targeting legislative change.
International Network of People who Use Drugs (INPUD): Global peer-led network of people who use drugs advocating for health, human rights, and decriminalisation. Highly comparable network-of-members model and overlapping decriminalisation agenda with DPNSEE.
Correlation – European Harm Reduction Network: European network connecting harm reduction services, grassroots organisations, and health facilities. DPNSEE is a member, and Correlation operates a near-identical network-coordination and capacity-building model across Europe.
Vienna NGO Committee on Drugs (VNGOC): NGO liaison body bridging civil society and UN drug control agencies (CND, INCB, UNODC). DPNSEE is a member and operates overlapping functions in regional advocacy and CND engagement.
Release: UK drugs charity providing legal and harm reduction services and policy advice. Co-author with UNAIDS/UNDP of the 2026 decriminalisation guidance note DPNSEE distributes; near-identical niche focus.
AFEW International: Dutch-based foundation working on HIV, TB, and harm reduction among key populations in Eastern Europe and Central Asia. Comparable regional NGO working with vulnerable populations and member organisations in a similar geography.

Broad incumbents

Harm Reduction International (HRI): Global harm reduction NGO leading advocacy, research, and the International Harm Reduction Conference. Operates in a wider portfolio than DPNSEE but addresses an overlapping substance use and human rights constituency.
Drug Policy Alliance (DPA): Largest US-based drug policy reform organisation driving state-level decriminalisation, harm reduction, and advocacy. Operates a much larger portfolio but pursues an identical drug-policy reform agenda as DPNSEE.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Drug Policy Network South East Europe financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Drug Policy Network South East Europe leadership team

Management profile

Number of profiles

Profiles3 records

Drug Policy Network South East Europe funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Drug Policy Network South East Europe M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Drug Policy Network South East Europe

What does Drug Policy Network South East Europe do?

Is Drug Policy Network South East Europe a public or private company?

Drug Policy Network South East Europe is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Drug Policy Network South East Europe founded?

Drug Policy Network South East Europe was founded in -1. It employs 1 to 10 people.

Where is Drug Policy Network South East Europe based?

Drug Policy Network South East Europe is headquartered in Belgrade (Zemun), Serbia, in the Europe region.

How does Drug Policy Network South East Europe make money?

One revenue line is on record: institutional Funding.

Who are Drug Policy Network South East Europe's main competitors?

Direct peers on record are International Drug Policy Consortium (IDPC), Eurasian Harm Reduction Association (EHRA), Transform Drug Policy Foundation, International Network of People who Use Drugs (INPUD), Correlation – European Harm Reduction Network, Vienna NGO Committee on Drugs (VNGOC), Release and AFEW International. Broad incumbents are Harm Reduction International (HRI) and Drug Policy Alliance (DPA).

Does Drug Policy Network South East Europe have an API?

No public API is recorded for Drug Policy Network South East Europe.

What industry is Drug Policy Network South East Europe in?

Drug Policy Network South East Europe's product category is Drug Policy Advocacy & Harm Reduction Network Services. Its primary akta.pro industry code is BPAGACAE, Substance Use Disorder Prevention & Recovery Services, with a secondary code of BPAGAEAO, Substance Use Recovery & Harm Reduction Support Services. Its NAICS code is 813212 and its SIC code is 8600.